Real-world data show TRD costs spike during resistant episodes; Compass’ psilocybin COMP360 delivers durable symptom relief through 26 weeks, potentially easing resource strain.
Poll|Articles|June 20, 2025
Poll: Do You Believe in an Afterlife?
Author(s)Psychiatric Times Editors
Listen
0:00 / 0:00
Key Takeaways
- H. Steven Moffic, MD, examines death, dying, past lives, and the afterlife, linking them to mental health.
- Parapsychology's potential impact on mental well-being is highlighted, suggesting therapeutic applications.
Share your thoughts on death and dying in this brief poll!
Advertisement
Earlier today, H. Steven Moffic, MD, shared his thoughts on death, dying, past lives, and the afterlife in his daily column, "
Do you believe in an afterlife?
Do you believe in past lives?
In your opinion, can talking about death help relieve death anxiety or fear?
Do you talk with your patients about death?
Share your thoughts on death and dying with us at
Advertisement
Related to this article
Antipsychotic levels clarify adherence, guide dose escalation up to a point of futility, and offer more than pharmacogenetic testing, says Jonathan Meyer, MD.
Learn how clinicians tailor antidepressants by diagnosis, symptoms, adverse effects, and next-step strategies for treatment-resistant depression.
How to interpret antipsychotic drug levels in schizophrenia: when labs mislead, when levels help adherence and toxicity checks, and why serial monitoring matters.
Male athletes with anorexia often go unnoticed as “discipline”; learn red flags, sport-specific risks, health consequences, and treatment steps for earlier diagnosis.
Explore major depression subtypes—from melancholic to inflammatory—and how they shape symptoms, biology, and treatment choices for better outcomes.
Therapeutic drug monitoring takes guesswork out of antipsychotic care—spotting nonadherence, guiding dose targets, and defining response thresholds and the “point of futility” in schizophrenia.
A psychiatric NP shares mentorship lessons, training fixes, and her Psych NP Boot Camp—plus practical tips to close prescriber gaps and improve team-based care.
Advertisement
Advertisement
Trending on Psychiatric Times
1
How Best to Manage Treatment-Resistant Depression
2
Antipsychotic Plasma Levels in Schizophrenia: Detecting Nonadherence and Guiding Dose Decisions
3
Podcast: Using Antipsychotic Plasma Levels to Guide Schizophrenia Treatment With Jonathan M. Meyer, MD
4
Choosing an Antidepressant: Art, Science, and Knowing Your Patient
5